Ken Cacciatore

Stock Analyst at TD Cowen

(0.33)
# 4,270
Out of 5,044 analysts
12
Total ratings
30%
Success rate
-28.61%
Average return

Stocks Rated by Ken Cacciatore

Arcutis Biotherapeutics
Aug 9, 2023
Maintains: Outperform
Price Target: $65$50
Current: $25.29
Upside: +97.71%
Bausch Health Companies
Jun 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.90
Upside: -
Takeda Pharmaceutical Company
May 16, 2023
Maintains: Outperform
Price Target: $30$20
Current: $13.77
Upside: +45.24%
Bausch + Lomb
May 11, 2022
Initiates: Outperform
Price Target: $35
Current: $15.47
Upside: +126.24%
Molecular Partners AG
Jul 13, 2021
Initiates: Outperform
Price Target: $50
Current: $3.74
Upside: +1,236.90%
Protara Therapeutics
Oct 19, 2020
Initiates: Outperform
Price Target: $50
Current: $5.20
Upside: +861.54%
Biohaven
Apr 17, 2020
Initiates: Outperform
Price Target: $45
Current: $18.11
Upside: +148.48%
Amarin Corporation
Mar 2, 2020
Initiates: Outperform
Price Target: $460
Current: $16.81
Upside: +2,636.47%